Cutting-edge science that could benefit patients too often never makes it out of the lab

Posted on January 27th, 2020

Academic research has always played a vital role in drug discovery, but getting research from the lab to patients is a complex, time consuming process with many barriers. We need more effective partnerships between universities and the pharmaceutical industry experts to bring basic biomedical discoveries from bench to bedside. That’s the mission of SPARK at Stanford…and we’re succeeding. Read more about this challenge and SPARK in an article published in the Washington Post, written by Jon Marcus #Stanford#biotech

Here is the link: